DE69612660D1 - Pseudotypisierte retrovirale vektoren - Google Patents
Pseudotypisierte retrovirale vektorenInfo
- Publication number
- DE69612660D1 DE69612660D1 DE69612660T DE69612660T DE69612660D1 DE 69612660 D1 DE69612660 D1 DE 69612660D1 DE 69612660 T DE69612660 T DE 69612660T DE 69612660 T DE69612660 T DE 69612660T DE 69612660 D1 DE69612660 D1 DE 69612660D1
- Authority
- DE
- Germany
- Prior art keywords
- retroviral vector
- pseudotypized
- retroviral vectors
- retroviral
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001177 retroviral effect Effects 0.000 title abstract 6
- 239000013598 vector Substances 0.000 title abstract 4
- 239000002245 particle Substances 0.000 abstract 2
- 241000713333 Mouse mammary tumor virus Species 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13051—Methods of production or purification of viral material
- C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Optical Radar Systems And Details Thereof (AREA)
- Eye Examination Apparatus (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dental Preparations (AREA)
- Developing Agents For Electrophotography (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK32795 | 1995-03-29 | ||
PCT/EP1996/001348 WO1996030533A1 (en) | 1995-03-29 | 1996-03-27 | Pseudotyped retroviral particles |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69612660D1 true DE69612660D1 (de) | 2001-06-07 |
DE69612660T2 DE69612660T2 (de) | 2002-04-18 |
Family
ID=8092296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69612660T Expired - Lifetime DE69612660T2 (de) | 1995-03-29 | 1996-03-27 | Pseudotypisierte retrovirale vektoren |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0817860B1 (de) |
JP (1) | JPH11502706A (de) |
AT (1) | ATE200912T1 (de) |
AU (1) | AU5274696A (de) |
DE (1) | DE69612660T2 (de) |
DK (1) | DK0817860T3 (de) |
ES (1) | ES2157435T3 (de) |
WO (1) | WO1996030533A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7470096A (en) * | 1995-10-05 | 1997-04-28 | Chiron Corporation | Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences |
ATE207963T1 (de) | 1997-02-27 | 2001-11-15 | Bundesrepublik Deutschland Let | Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen |
EP0938904A1 (de) * | 1998-02-09 | 1999-09-01 | Leuven Research & Development vzw | Säugetierzelltransduktion zur Verwendung in Gentherapie |
CA2289918A1 (en) * | 1997-05-16 | 1998-11-26 | Leuven Research & Development Vzw | Mammalian cell transduction for use in gene therapy |
FR2779445B1 (fr) * | 1998-06-08 | 2000-08-11 | Univ Nantes | Kit d'encapsidation |
GB0400443D0 (en) | 2004-01-09 | 2004-02-11 | Oxford Biomedica Ltd | Cascade |
EP1427836A2 (de) * | 2001-09-21 | 2004-06-16 | Oxford Biomedica (UK) Limited | Pseudotyped retrovirales vektorsystem |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69420033T2 (de) * | 1993-04-06 | 1999-12-23 | Us Gov Health & Human Serv | Gibbon leukemia virus retrovirale vektoren |
-
1996
- 1996-03-27 AT AT96909135T patent/ATE200912T1/de active
- 1996-03-27 WO PCT/EP1996/001348 patent/WO1996030533A1/en active IP Right Grant
- 1996-03-27 EP EP96909135A patent/EP0817860B1/de not_active Expired - Lifetime
- 1996-03-27 AU AU52746/96A patent/AU5274696A/en not_active Abandoned
- 1996-03-27 DE DE69612660T patent/DE69612660T2/de not_active Expired - Lifetime
- 1996-03-27 DK DK96909135T patent/DK0817860T3/da active
- 1996-03-27 ES ES96909135T patent/ES2157435T3/es not_active Expired - Lifetime
- 1996-03-27 JP JP8528928A patent/JPH11502706A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU5274696A (en) | 1996-10-16 |
DK0817860T3 (da) | 2001-10-01 |
ATE200912T1 (de) | 2001-05-15 |
DE69612660T2 (de) | 2002-04-18 |
EP0817860A1 (de) | 1998-01-14 |
JPH11502706A (ja) | 1999-03-09 |
ES2157435T3 (es) | 2001-08-16 |
EP0817860B1 (de) | 2001-05-02 |
WO1996030533A1 (en) | 1996-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2331522A (en) | Lentiviral vectors | |
GB2325003A (en) | Rectroviral vectors | |
CA2324028A1 (en) | Retroviral packaging cell line | |
ATE381624T1 (de) | Retrovirale vektoren mit verminderter rekombinationsrate | |
ATE291632T1 (de) | Auf lentivirus basierende gentransfer-vektoren | |
MX9205244A (es) | Micelas modificadas de caseina. | |
DE69612660T2 (de) | Pseudotypisierte retrovirale vektoren | |
EP1006196A3 (de) | Retrovirale, mit LCMV-Glykoprotein pseudotypisierte Hybrid-Vektoren | |
NO975813L (no) | Innkapslede celler som produserer virale partikler | |
DE3789400D1 (de) | Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper. | |
DE69739251D1 (de) | Nicht-m nicht-o hiv-1-stamm, fragmente und verwendungen | |
WO2002042482A3 (en) | Functional lentiviral vector from an mlv-based backbone | |
CA2464268A1 (en) | Regulated nucleic acid expression system | |
ES2184059T3 (es) | Vector retrovirico y su utilizacion en terapia genica. | |
NO20002013D0 (no) | Suspensjonsforpakningscellelinjer for retrovirusvektorer | |
AU2190288A (en) | Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained | |
WO1995025806A3 (en) | Packaging-deficient lentiviruses | |
CA2331440A1 (en) | Amphotropic retrovirus packaging cell line, process for its production and use thereof | |
WO2002034929A3 (en) | Expression vectors and uses thereof | |
EP1129100A4 (de) | Auswahlverfahren zur erzeugung effizienter pack-zellen für lentivirale vektoren | |
WO1999025862A3 (en) | Chimeric viral packaging signal without gag gene sequences |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: GSF - FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNG, DE |